Biomarkers and Clinical Toxicology - Publications

Publications of the Basel Group

• [24a]. Maachi M, Fellahi S, Regeniter A, Diop ME, Capeau J, Rossert J, Bastard JP.
  Patterns of proteinuria: urinary sodium dodecyl sulfate electrophoresis versus immunonephelometric protein marker measurement followed by interpretation with the knowledge-based system MDI-LabLink.
  Clin Chem 2004;50(10):1834-7.

Publications of the Geneva Groups

• [59]. Lazarou J, Pomeranz BH, Corey PN.
  Incidence of adverse drug reactions in hospitalized patients.
  JAMA. 1998; 279: 1200-1205.
• [60]. Starfield B.
  Is US health really the best in the world?
  JAMA. 2000; 284: 483-485.
• [61]. Evans RC, Classen DC, Horn SD, Bass SB, Burke JP.
  Preventing adverse drug events in hospitalized patients.
  Ann Pharmacother. 1994; 28: 523-527.
• [62]. Y.Gasche, Y.Daali, M.Fathi, A.Chiappe, S.Cottini, P. Dayer and J. Desmeules;
  Codeine intoxication associated with ultrarapid CYP2D6 metabolism,
  The new England Journal of Medecine , (2004), 351, p.2827– 2831.
• [63]. L.A.Leuthold, J.F.Mansdscheff, M.Fathi, C.Giroud, M.Auggsburger, E.Varesio and G. Hopfgartner ;
  Desorption electrospray ionization mass spectrometry : direct toxicological screening and analysis of illicit ecctasy tablets,
  Rapid communications in mass spectrometry,2006, (20) p.103-110.
• [64]. N.Ansermot, M.Fathi, J-L.Veuthey, J.Desmeules, D.Hochstrasser, S.Rudaz;
  Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column- switching approach;
  J Chrom B 2007, (857) p.92 – 99.
• [65]. Rebsamen M.C., Desmeules J., Daali Y., Chiappe A., Diemand A., Rey C.,Chabert J., Dayer P., Hochstrasser D., Rossier M.F.
  The AmpliChip® CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
  The Pharmacogenomics Journal, In Press May, 2008
• [66]. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A.
  DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility tocancers of the upper aerodigestive tract.
  Int J Cancer. 2004 Dec 10;112(5):901-4. (imp Fact 4.69)
• [67]. Bouchardy C, Benhamou S, Jourenkova N, Dayer P, Hirvonen A.
  Metabolic genetic polymorphisms and susceptibility to lung cancer.
  Lung Cancer. 2001 May;32(2):109-12. (Imp Fact 3.55)
• [68]. Bouchardy C, Benhamou S, Dayer P. Re: London,S.J. et al. (1997)
  Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
  Carcinogenesis, 18, 1203-1214. Carcinogenesis. 1998 Mar;19(3):533-5.

Last Updated on Thursday, 25 March 2010 15:47 Created: Tuesday, 07 April 2009 12:57